Advanced Filter

Filter by Group

Filter by Market Availability

Filter by Biologic Group

Displaying drugs 1 - 25 of 406 in total
Name Weight StructureDesriptionCategories
Vosoritide4100.0

C176H290N56O51S3
An analogue of C-type naturietic peptide used to promote bone growth in pediatric patients with achondroplasia.C-type Natriuretic Peptide Analog
Vonicog alfa20000000.0

Vonicog alfa is indicated for the on-demand treatment and control of bleeding episodes in adults previously diagnosed with von Willebrand disease. Vonicog alfa contains only the vWF and thus, its...Not Available
Von Willebrand factor humanNot AvailableA blood clotting factor used to manage bleeding episodes in von Willebrand disease and hemophilia A.Blood Coagulation Factors / von Willebrand Factor / von Willebrand Factor, antagonists & inhibitors
Vestronidase alfa72562.0

A recombinant beta-glucuronidase used to treat mucopolysaccharidosis VII.Enzymes
Velmanase alfaNot AvailableA recombinant human lysosomal alpha-mannosidase used to treat non-neurological symptoms of mild to moderate alpha-mannosidosis.Enzymes
Velaglucerase alfa63000.0

C2532H3850N672O711S16
An enzyme replacement therapy used for the long-term treatment of for pediatric and adult patients with type 1 Gaucher disease.Enzymes / Hydrolytic Lysosomal Glucocerebroside-specific Enzyme
Vedolizumab146837.0

C6528H10072N1732O2042S42
An integrin blocker and anti-inflammatory agent used to manage ulcerative colitis and Crohn's disease in adults.Selective Immunosuppressants
Ustekinumab148600.0

A targeted antibody therapy used to manage inflammatory conditions such as plaque psoriasis, psoriatic arthritis, Crohn's Disease, and ulcerative colitis.Interleukin Inhibitors
Urokinase31126.5

C1376H2145N383O406S18
A low molecular weight form of human urokinase used to treat pulmonary embolism and myocardial infarction as well as to clear IV lines.Enzymes
Urofollitropin980.162

C42H65N11O12S2
A form of purified human follicle stimulating hormone used to treat infertility in females by inducing follicle development in women without primary ovarian failure.Gonadotropins
Ublituximab147000.0

A low-fucose CD20-targeted monoclonal antibody used in the treatment of relapsing forms of multiple sclerosis.Selective Immunosuppressants
Turoctocog alfa pegolNot AvailableTuroctocog alfa pegol is indicated for use in adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to...Amino Acids, Peptides, and Proteins / Biological Factors / Blood Coagulation Factors / Blood Proteins / Factor VIII / Hemostatics / Proteins / Recombinant Proteins
Turoctocog alfa166000.0

C7480H11379N1999O2194S68
An antihemorrhagic agent used for the treatment and prophylaxis of bleeding in patients of all ages with haemophilia A (congenital factor VIII deficiency).Recombinant Proteins
Tuberculin purified protein derivativeNot AvailableA purified protein used in the Mantoux test for Mycobacterium tuberculosis testing.Antigens, Bacterial / Indicators and Reagents / Skin Test Antigen / Tuberculin / Tuberculosis Skin Test
Tremelimumab149000.0

C6500H9974N1726O2026S52
An anti-CTLA-4 antibody used to treat unresectable hepatocellular carcinoma in combination with durvalumab.Antineoplastic Agents
Trastuzumab emtansineNot AvailableAn antineoplastic agent and antibody-drug conjugate used to treat HER2-overexpressing breast cancer.Antibodies, Monoclonal / HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
Trastuzumab deruxtecanNot AvailableAn antibody used to treat certain types of unresectable or metastatic HER2 positive breast cancer.HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
Trastuzumab145531.5

C6470H10012N1726O2013S42
A monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers.Antibodies, Monoclonal / HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
Tralokinumab147000.0

C6374H9822N1698O2014S44
A monoclonal antibody directed against interleukin-13 which is used in the treatment of moderate-to-severe atopic dermatitis in patients requiring systemic therapy.Agents for Dermatitis, Excluding Corticosteroids
Tositumomab143859.7

C6416H9874N1688O1987S44
A monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope.Iodine (131I) Compounds
Toripalimab150000.0

A PD-1 blocking monoclonal antibody used for the treatment of metastatic and recurrent nasopharyngeal carcinomas.Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Blood Proteins / Globulins / Immune Checkpoint Inhibitors / Immunoglobulins / Immunoproteins / Programmed Death Receptor-1 Blocking Antibody / Proteins / Serum Globulins
Tocilizumab148000.0

C6428H9976N1720O2018S42
An interleukin-6 (IL-6) receptor antagonist used to treat Cytokine Release Syndrome (CRS), Systemic Juvenile Idiopathic Arthritis (sJIA), Giant Cell Arteritis (GCA), and Rheumatoid Arthritis (RA).Interleukin Inhibitors
Tixagevimab149000.0

C6488H10034N1746O2038S50
An extended half-life recombinant monoclonal IgG1κ antibody directed against the SARS-CoV-2 S protein for COVID-19 prophylaxis in individuals unable to undergo COVID-19 immunization.Antiviral monoclonal antibodies
Tisotumab vedotin153000.0

A tissue factor-directed antibody drug conjugate that is used to treat adults with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.Antineoplastic Agents, Immunological
TislelizumabNot AvailableAn IgG4 variant monoclonal antibody against PD-1 indicated for the treatment of unresectable, locally advanced or metastatic esophageal squamous cell carcinomaPD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors
Displaying drugs 1 - 25 of 406 in total